Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
An international phase II trial
Primary outcome measures:
Progression-free Survival (PFS)
The authors concluded that this is the first demonstration of the clinical activity of PD-1 blockade in DLBCL. Given these results, PD-1 blockade after AHSCT using pidilizumab may represent a promising therapeutic strategy for this disease.
Armand et al. 2013 J Clin Oncol 31: 4199–4206
…